References in periodicals archive ?
2 is a potassium channel -- it forms a pore through the cell membrane that allows potassium ions to enter the cell.
Contract notice: Service as part of a research project "high-throughput screening for new activating substances of the potassium channel trek1".
In 2013, Xention entered into an agreement with Servier for the development and commercialisation of XEN-D0103, a potent and selective oral modulator of the cardiac potassium channel Kv1.
It is described in the literature that several natural occurring compounds can block different types of potassium channel.
This finding is of importance because ezogabine acts by opening a particular type of potassium channel in the brain, called the Kv7 channel, which regulates activity in areas of the brain that are believed to regulate the rewarding effects of alcohol," explains lead author Clifford Knapp, associate professor of psychiatry.
Clifford Knapp lead author of the story said that the finding is of importance because ezogabine acts by opening a particular type of potassium channel in the brain, called the Kv7 channel, which regulates activity in areas of the brain that are believed to regulate the rewarding effects of alcohol.
The sustained-release formulation of the potassium channel blocker dalfampridine, marketed as Ampyra by Acorda Therapeutics, was approved in January 2010 to improve walking in people with multiple sclerosis, at a dose of 10 mg twice a day.
The drug, a selective inhibitor of the cardiac potassium channel Kv1.
2+]-activated potassium channel (BKCa) and voltage-sensitive potassium channel (KV) opening action, but testosterone-induced vasodilatation has been shown to occur via ATP-sensitive potassium channel (KATP) opening action in dog coronary resistance arteries.
Other topics of the ten papers include the etiology of obesity-induced insulin resistance, chosen life aspects of diabetic patients, the impact of oxidative stress, CNS amyloidosis, stem cell therapy, the effect of reactive oxygen species on potassium channel function, and views of type 2 diabetes causality in Mexico.
A sustained-release formulation of the potassium channel blocker dalfampridine has been approved as a treatment to improve walking in people with multiple sclerosis.
sales force, increase its international presence, fund certain clinical outcome studies, advance its lead potassium channel blocker compound to a Phase I milestone, as well as for other general working capital purposes.

Full browser ?